Skip to content

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Menu

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

NASDAQ:MYGN

Tag
NASDAQ:MYGN

Finance

Myriad Genetics Inc. [MYGN] Revenue clocked in at $566.10 million, up 66.62% YTD: What’s Next?

Edison Baldwin July 14, 2021

Finance

BofA/Merrill lifts Myriad Genetics Inc. [MYGN] price estimate. Who else is bullish?

Misty Lee September 22, 2020

Companies

Market Analysts see Myriad Genetics Inc. [MYGN] falling to $28. Time to buy?

Brandon Evans September 2, 2020

Market

Myriad Genetics Inc. [MYGN] Revenue clocked in at $760.80 million, down -50.86% YTD: What’s Next?

Annabelle Farmer August 14, 2020

Market

why Myriad Genetics Inc. [MYGN] is a Good Choice for Investors After New Price Target of $18.67

Brandon Evans June 19, 2020

Companies

Myriad Genetics Inc. [MYGN] Stock trading around $15.63 per share: What’s Next?

Misty Lee June 11, 2020

Company

HomePage
About US
Our Team
Contact US
STOCK STORIES

Categories

Companies
Equity Analysis
Finance
Market
Stock Stories

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Email

© DBT NEWS. All rights reserved.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

About Us
Contact Us
Homepage
Our Team
Thank You